Plotkin Financial Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.3M Hold
10,131
– – 0.54% 35
2026
Q1
$1.22M Buy
10,131
+29
+0.3% +$3.35K 0.61% 33
2025
Q4
$1.06M Hold
10,102
– – 0.52% 37
2025
Q3
$848K Hold
10,102
– – 0.42% 40
2025
Q2
$800K Hold
10,102
– – 0.44% 39
2025
Q1
$907K Hold
10,102
– – 0.56% 35
2024
Q4
$1M Hold
10,102
– – 0.6% 34
2024
Q3
$1.15M Hold
10,102
– – 0.69% 32
2024
Q2
$1.25M Hold
10,102
– – 0.8% 30
2024
Q1
$1.33M Buy
+10,102
New +$1.25M 0.88% 29

Other funds holding MRK

Plotkin Financial Advisors's MRK Position: Q2 2026 in Review

Plotkin Financial Advisors held its Merck (MRK) position steady in Q2 2026 at 10,131 shares worth $1.3M. The position accounts for 0.54% of the portfolio, ranked #35.

Plotkin Financial Advisors first reported a position in MRK in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.33M in Q1 2024. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Plotkin Financial Advisors held 10,131 shares of Merck worth $1.3M as of Q2 2026.
  • Plotkin Financial Advisors left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.54% of Plotkin Financial Advisors's portfolio in Q2 2026, its #35 holding.
  • Plotkin Financial Advisors first reported a position in Merck in Q1 2024 and has held it in 10 quarters since.
  • Plotkin Financial Advisors's Merck position peaked at $1.33M in Q1 2024.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Plotkin Financial Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.